Oncode Quarterly Magazine - October 2019
News
15 October 2019
Oncode Quarterly Magazine - October 2019
Welcome to the second edition of our quarterly magazine. Are you curious what kept us busy the past few months? In this edition you can read interviews with Jannie Borst, Andrea van Elsas, Ruben van Boxtel and Rebekka Schneider. And there's much more!
Vesnade Jong
Geert Kops receives ERC Synergy Grant
News
11 October 2019
Geert Kops receives ERC Synergy Grant
Oncode's Scientific Director Geert Kops (Hubrecht Institute) has received a European Research Council (ERC) Synergy Grant to investigate the causes and effects of chromosomal aberrations in cancer, together with Iva Tolic (Ruder Boskovic Institute), Angelika Amon (Massachusetts Institute of Technology) and Nenad Pavin (University of Zagreb). Together they receive 10 million euros for their interdisciplinary effort that combines cell biology, bio(physics) and genetics.
ElizeBrolsma
The mutational impact of fluoropyrimidines
News
11 October 2019
The mutational impact of fluoropyrimidines
In their latest paper in Nature Communications, Oncode Investigator Edwin Cuppen and Arne van Hoeck (UMC Utrecht), together with colleagues, assess the mutational impact of fluoropyrimidines.
ElizeBrolsma
ESMO 2019: what have we learnt?
News
10 October 2019
ESMO 2019: what have we learnt?
While the autumn started showing itself in some parts of Europe, the sun was shining in the city of Gaudi which was home to more than 28,000 attendees for the ESMO 2019 annual congress. For one week, Barcelona was flooded with top-quality science and ambitious visions that will shape the future of cancer therapies.
YuvaOz
'One-two punch' method published in Nature
News
3 October 2019
'One-two punch' method published in Nature
The labs from Oncode Investigators René Bernards and Leila Akkari (NKI) have published the results of important research in Nature. Many combinations of cancer medicines could theoretically work very well together, but in practice these combinations are too toxic for the body to withstand. The researchers devised a possible alternative: the 'one-two punch', named after the effective combination of two quick successive punches in boxing.
ElizeBrolsma

Meet Oncode

Fundamental science, clinical testing and a sharp mind for market opportunities: at Oncode we bring it all together to create impact for patients.
https://www.oncode.nl/about/in-het-nederlands
About
In het Nederlands
Oncode is een internationale organisatie. Maar gezien onze oorsprong vertellen we ons verhaal ook graag in het Nederlands.
https://www.oncode.nl/about/founding-principles
About
Our founding principles
We want to understand cancer - but that's only the start. Discover what Oncode stands for in 9 statements.
https://www.oncode.nl/about
About
Getting acquainted
Whether you're looking for a chart or contact information, and whether you're a PhD, a partner or a patient: pleased to meet you.
Valorization
Speeding-up the processes
How can we bring effective and affordable technologies to patients faster? Read about this and other concerns in our valorization strategy.